Table 2.
Variable | Non-coplanar intensity-modulated radiotherapy plan | Stereotactic body radiotherapy plan | p-value |
---|---|---|---|
Clinical target volume (ml) | 9.99 (range, 1.16–42.82) |
||
PTV volume (ml) | 34.84 (range, 6.59–88.85) |
||
PTV coverage (%) | |||
V100% | 86.9 ± 12.0 | 86.7 ± 15.5 | 0.59 |
V95% | 98.9 ± 2.8 | 99.3 ± 0.9 | 0.20 |
V90% | 99.7 ± 0.9 | 99.9 ± 0.2 | 0.34 |
Radiation Therapy Oncology Group CI | 1.05 ± 0.21 | 1.47 ± 0.21 | <0.001 |
Healthy tissue CI | 0.84 ± 0.09 | 0.63 ± 0.14 | <0.001 |
CN | |||
CN 100 | 0.72 ± 0.10 | 0.53 ± 0.13 | <0.001 |
CN 75 | 0.33 ± 0.08 | 0.27 ± 0.06 | <0.001 |
CN 50 | 0.18 ± 0.04 | 0.15 ± 0.04 | <0.001 |
Homogeneity index | 1.04 ± 0.03 | 1.11 ± 0.03 | <0.001 |
CI, conformity index; CN, conformal number; PTV, planning target volume; Vx%, the volume receiving ≥x% of the prescribed dose.
Parameters are calculated by Wilcoxon signed-rank sum test.